Envestnet Asset Management’s Puma Biotechnology PBYI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$241K Sell
24,234
-4,956
-17% -$43.6K ﹤0.01% 4664
2026
Q2
$237K Buy
29,190
+2,632
+10% +$19.3K ﹤0.01% 4572
2026
Q1
$170K Buy
+26,558
New +$171K ﹤0.01% 4547
2021
Q4
– Sell
-135,226
Closed -$948K – 3926
2021
Q3
$948K Buy
135,226
+1,946
+1% +$14.6K ﹤0.01% 2580
2021
Q2
$1.22M Buy
133,280
+5,518
+4% +$55.9K ﹤0.01% 2390
2021
Q1
$1.24M Buy
127,762
+106,424
+499% +$1.19M ﹤0.01% 2239
2020
Q4
$219K Buy
21,338
+360
+2% +$3.64K ﹤0.01% 3092
2020
Q3
$212K Buy
20,978
+217
+1% +$2.21K ﹤0.01% 2891
2020
Q2
$217K Sell
20,761
-1,296
-6% -$13.4K ﹤0.01% 2837
2020
Q1
$186K Buy
22,057
+10,619
+93% +$103K ﹤0.01% 2750
2019
Q4
$100K Buy
11,438
+219
+2% +$1.81K ﹤0.01% 2998
2019
Q3
$121K Buy
+11,219
New +$121K ﹤0.01% 2942
2019
Q2
– Sell
-6,536
Closed -$254K – 3065
2019
Q1
$254K Buy
+6,536
New +$200K ﹤0.01% 2703
2018
Q3
– Sell
-190
Closed -$11K – 2204
2018
Q2
$11K Sell
190
-8
-4% -$464 ﹤0.01% 2520
2018
Q1
$13K Buy
198
+55
+38% +$4.12K ﹤0.01% 2455
2017
Q4
$14K Buy
143
+49
+52% +$5.48K ﹤0.01% 2573
2017
Q3
$11K Buy
+94
New +$8.74K ﹤0.01% 2581
2016
Q3
– Sell
-1,613
Closed -$48K – 3006
2016
Q2
$48K Sell
1,613
-10
-0.6% -$313 ﹤0.01% 2747
2016
Q1
$48K Buy
1,623
+420
+35% +$19K ﹤0.01% 2736
2015
Q4
$94K Sell
1,203
-260
-18% -$20.4K ﹤0.01% 2392
2015
Q3
$110K Buy
+1,463
New +$138K ﹤0.01% 2298
2014
Q4
– Sell
-5
Closed -$1K – 2662
2014
Q3
$1K Sell
5
-3
-38% -$616 ﹤0.01% 2632
2014
Q2
$1K Hold
8
– – ﹤0.01% 2614
2014
Q1
$1K Buy
+8
New +$940 ﹤0.01% 2436

Other funds holding PBYI

Envestnet Asset Management's PBYI Position: Q3 2026 in Review

Envestnet Asset Management reduced its Puma Biotechnology (PBYI) stake by 17% in Q3 2026, selling an estimated $43.6K and leaving 24,234 shares worth $241K. The position accounts for ﹤0.01% of the portfolio, ranked #4664.

Envestnet Asset Management first reported a position in PBYI in Q1 2014 and has held it in 24 quarters since. The position peaked at $1.24M in Q1 2021. 156 funds tracked by Wall St. Rank hold PBYI as of Q3 2026.

  • Envestnet Asset Management held 24,234 shares of Puma Biotechnology worth $241K as of Q3 2026.
  • Envestnet Asset Management sold 4,956 Puma Biotechnology shares in Q3 2026, an estimated $43.6K.
  • Puma Biotechnology made up ﹤0.01% of Envestnet Asset Management's portfolio in Q3 2026, its #4664 holding.
  • Envestnet Asset Management first reported a position in Puma Biotechnology in Q1 2014 and has held it in 24 quarters since.
  • Envestnet Asset Management's Puma Biotechnology position peaked at $1.24M in Q1 2021.
  • 156 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2026.

Based on Envestnet Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.